Literature DB >> 18720170

Lung deposition of droplet aerosols in monkeys.

Y S Cheng1, H Irshad, P Kuehl, T D Holmes, R Sherwood, C H Hobbs.   

Abstract

Nonhuman primates are often the animal models of choice to study the infectivity and therapy of inhaled infectious agents. Most animal models for inhaled infectious diseases use aerosol/droplets generated by an atomization technique such as a Collison nebulizer that produces particles in the size range of 1 to 3 microm in diameter. There are few data in the literature on deposition patterns in monkeys. Our study was designed to measure the deposition pattern in monkeys using droplets having diameters of 2 and 5 microm using an exposure system designed to expose monkeys to aerosols of infectious agents. Six cynomolgus monkeys were exposed to droplets. The aerosol solution was generated from a Vero cell supernate containing DMEM + 10% fetal bovine serum tagged with Tc-99m radiolabel. Collison and Retec nebulizers were used to generate small and large droplets, respectively. The particle size (as determined from a cascade impactor) showed an activity median aerodynamic diameter (AMAD) of 2.3 and 5.1 microm for the Collison and Retec nebulizer, respectively. The animals were anesthetized, placed in a plethysmography box, and exposed to the aerosol. The deposition pattern was determined using a gamma camera. Deposition in the head airways was 39% and 58% for 2.3- and 5.1-microm particle aerosols, respectively, whereas the deposition in the deep lung was 12% and 8%, respectively. This information will be useful in developing animal models for inhaled infectious agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18720170     DOI: 10.1080/08958370802105413

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  11 in total

1.  Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation.

Authors:  R Colby Layton; Trevor Brasel; Andrew Gigliotti; Edward Barr; Steven Storch; Leslie Myers; Charles Hobbs; Frederick Koster
Journal:  J Med Primatol       Date:  2010-08-16       Impact factor: 0.667

2.  Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques.

Authors:  Diane L Bolton; Kaimei Song; Georgia D Tomaras; Srinivas Rao; Mario Roederer
Journal:  Vaccine       Date:  2016-12-29       Impact factor: 3.641

3.  Generation and characterization of large-particle aerosols using a center flow tangential aerosol generator with a non-human-primate, head-only aerosol chamber.

Authors:  J Kyle Bohannon; Matthew G Lackemeyer; Jens H Kuhn; Jiro Wada; Laura Bollinger; Peter B Jahrling; Reed F Johnson
Journal:  Inhal Toxicol       Date:  2015-05-13       Impact factor: 2.724

4.  Milestones in progression of primary pneumonic plague in cynomolgus macaques.

Authors:  Frederick Koster; David S Perlin; Steven Park; Trevor Brasel; Andrew Gigliotti; Edward Barr; Leslie Myers; Robert C Layton; Robert Sherwood; C R Lyons
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

5.  Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses.

Authors:  Michelle Meyer; Tania Garron; Ndongala M Lubaki; Chad E Mire; Karla A Fenton; Curtis Klages; Gene G Olinger; Thomas W Geisbert; Peter L Collins; Alexander Bukreyev
Journal:  J Clin Invest       Date:  2015-07-13       Impact factor: 14.808

6.  Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys.

Authors:  Joshua M DiNapoli; Baibaswata Nayak; Lijuan Yang; Brad W Finneyfrock; Anthony Cook; Hanne Andersen; Fernando Torres-Velez; Brian R Murphy; Siba K Samal; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

7.  Development of a rhesus monkey lung geometry model and application to particle deposition in comparison to humans.

Authors:  Bahman Asgharian; Owen Price; Gene McClellan; Rick Corley; Daniel R Einstein; Richard E Jacob; Jack Harkema; Stephan A Carey; Edward Schelegle; Dallas Hyde; Julia S Kimbell; Frederick J Miller
Journal:  Inhal Toxicol       Date:  2012-11       Impact factor: 2.724

8.  Utility of Three Nebulizers in Investigating the Infectivity of Airborne Viruses.

Authors:  Sadegh Niazi; Lisa K Philp; Kirsten Spann; Graham R Johnson
Journal:  Appl Environ Microbiol       Date:  2021-07-27       Impact factor: 4.792

9.  Levofloxacin cures experimental pneumonic plague in African green monkeys.

Authors:  Robert Colby Layton; William Mega; Jacob D McDonald; Trevor L Brasel; Edward B Barr; Andrew P Gigliotti; Frederick Koster
Journal:  PLoS Negl Trop Dis       Date:  2011-02-08

Review 10.  Innovations in modeling influenza virus infections in the laboratory.

Authors:  Kortney M Gustin; Jessica A Belser; Jacqueline M Katz; Terrence M Tumpey; Taronna R Maines
Journal:  Trends Microbiol       Date:  2012-04-19       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.